In our study, infection of a panel of murine and human glioma cells, including glioma stem cells, with Delta-24-GREAT resulted in expression of GITRL in more than 70% of the cells in vitro, and exogenous GITRL was detected in vivo after intratumoral injection. This evidence concerns the gene TNFSF18 and glioma.